Dipeptidyl peptidase-4 inhibitors and sulfonylureas for type 2 diabetes: Friend or foe?

J Diabetes Investig. 2014 Sep;5(5):475-7. doi: 10.1111/jdi.12229.

¹ Center for Diabetes, Endocrinology and Metabolism Osaka Japan ; Center for Metabolism and Clinical Nutrition Kansai Electric Power Hospital Osaka Japan ; Division of Molecular and Metabolic Medicine Kobe University Graduate School of Medicine Kobe Japan.
² Center for Diabetes, Endocrinology and Metabolism Osaka Japan.

No abstract available